The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Key Takeaways An immunotherapy drug can boost survival in people with stomach or esophageal cancerWhen combined with chemo, durvalumab eliminated cancer in nearly 1 in 5 patientsAfter two years ...

By Dennis Thompson HealthDay ReporterFRIDAY, June 6, 2025 (HealthDay News) — Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new ...

Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal cancer development, according to a study published in JAMA Network Open ...

Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help prevent esophageal cancer.

Health Here's what to know about esophageal cancer following Rep. Gerry Connolly's death Here's a closer look at what esophageal cancer is, who is at risk and where research stands now.

The IARC Handbooks of Cancer Prevention Program developed a two-part volume (Volume 20A and Volume 20B) on the primary prevention of alcohol-related cancers (Figure 1). 5 As described in Volume ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

Among patients with mismatch repair–deficient (dMMR), locally advanced rectal cancer, neoadjuvant checkpoint blockade eliminated the need for surgery in a high proportion of patients. Whether ...

Dysphagia is a common early symptom of esophageal cancer, often confused with digestive issues, delaying diagnosis. Treatment varies by cancer stage; early-stage often involves surgery and ...